Jean-Philippe Haymann
Overview
Explore the profile of Jean-Philippe Haymann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Letavernier E, Schwoehrer M, Livrozet M, Saint-Jacques C, Raymond L, Saraeva R, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2584.
PMID: 39156159
[This corrects the article DOI: 10.1016/j.ekir.2021.11.035.].
2.
Bouderlique E, Kervadec J, Tang E, Zaworski J, Coudert A, Rubera I, et al.
J Mol Med (Berl)
. 2024 Aug;
102(10):1217-1227.
PMID: 39136767
One of the hallmarks of chronic kidney disease (CKD) is the development of vascular calcification. Inorganic pyrophosphate is a potent inhibitor of calcification, and previous studies have reported low plasma...
3.
Normand M, Haymann J, Daudon M
Can Urol Assoc J
. 2024 Jul;
18(11):E339-E345.
PMID: 38976892
Introduction: The prevalence of uric acid (UA) stones increases regularly due to its high correlation with obesity, hypertension, metabolic syndrome, type 2 diabetes, and aging. Uric acid stone formation is...
4.
Halimi C, Bor C, Chieze R, Saint-Jacques C, Perie S, Wagner I, et al.
J Clin Endocrinol Metab
. 2024 Mar;
109(10):2553-2560.
PMID: 38497124
Context: Primary hyperparathyroidism (PHPT) is commonly diagnosed in the setting of hypercalcemia, whereas normocalcemic primary hyperparathyroidism (NHPT) may be misdiagnosed. Objective: Our objective was to compare patients with hypercalcemic hyperparathyroidism...
5.
Azencot R, Saint-Jacques C, Haymann J, Frochot V, Daudon M, Letavernier E
Sci Rep
. 2024 Mar;
14(1):6078.
PMID: 38480876
Cotrimoxazole (Trimethoprim/Sulfamethoxazole-SMX) is frequently used in critically ill and immunocompromised patients. SMX is converted to N-acetyl-sulfamethoxazole (NASM) and excreted by the kidneys. NASM may form crystals in urine, especially in...
6.
de Berny Q, Saint-Jacques C, Santin A, Mattioni S, Steichen O, Chieze R, et al.
Am J Physiol Renal Physiol
. 2023 Dec;
326(2):F278-F284.
PMID: 38059298
The urine concentration impairment responsible for hyposthenuria in sickle cell nephropathy is currently thought to be a consequence of renal medulla lesions, which lead to nephrogenic diabetes insipidus. The objective...
7.
Michon-Colin A, Metzger M, Bankir L, Gauci C, Brunel M, Baron S, et al.
Clin Kidney J
. 2023 Dec;
16(12):2472-2481.
PMID: 38046034
Background: Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to...
8.
Bienaime F, Muorah M, Metzger M, Broeuilh M, Houiller P, Flamant M, et al.
EBioMedicine
. 2023 Jun;
93:104635.
PMID: 37285616
Background: Urinary biomarkers may improve the prediction of chronic kidney disease (CKD) progression. Yet, data reporting the applicability of most commercial biomarker assays to the detection of their target analyte...
9.
Talbot J, Perie S, Tassart M, Delbot T, Aveline C, Zhang-Yin J, et al.
Q J Nucl Med Mol Imaging
. 2023 Mar;
67(2):96-113.
PMID: 36995286
Background: During the past decade, F-fluorocholine (FCH) PET/CT has been continuously performed at Tenon Hospital (Paris, France) for the detection of hyperfunctioning parathyroid glands (PT). Methods: A cohort of 401...
10.
Haymann J
Ann Endocrinol (Paris)
. 2023 Mar;
84(3):388-390.
PMID: 36965851
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) (Bartter and Schwartz, 1967) is defined as low effective plasma osmolality due to impaired renal water dilution together with impaired thirst...